Medennium, Inc.

Medennium designs, develops, manufactures, and markets implantable ophthalmic devices for the treatment of myopia, aphakia, hyperopia, and dry eye. The company has over 20 years of innovation in vision correction solutions. Product portfolio includes phakic intraocular lenses (MPL™ system) for permanent correction of severe myopia and hyperopia, conventional intraocular lenses (IOLs) manufactured from proprietary Aurium™ material with blue and violet light filtering capabilities, and SmartPLUG™ punctal plugs for dry eye management. The Aurium™ material supports small incision (sub-2.5 mm) injector compatibility in single-piece and three-piece lens configurations. SmartPLUG™ is a removable, shape-conforming tear duct plug registered in the United States, Europe, Latin America, and multiple Asian regions. The company distributes globally through international partnerships and maintains manufacturing and regulatory compliance across major markets. Products address both surgical cataract and refractive correction needs for ophthalmology practices and surgical centers.